When studying the effectiveness of SMP against mastitis, it was found that SMP supplementation could inhibit the activities of myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAGase) and reduce the expression of IL-6, IL-1β and TNF-α inflammatory factors in rats with mastitis. Here, IL1B is linked to mastitis.